eHealth Financial Statements (EHTH)
|
|
|
|
Report date
|
|
|
01.03.2022 |
01.03.2023 |
29.02.2024 |
27.02.2025 |
26.02.2026 |
|
07.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
538.2 |
405.4 |
452.9 |
532.4 |
554.0 |
|
528.9 |
|
Operating Income, bln rub |
|
|
-125.6 |
-102.7 |
-29.1 |
23.6 |
68.5 |
|
66.7 |
|
EBITDA, bln rub |
? |
|
-105.2 |
-77.7 |
0.295 |
46.8 |
83.2 |
|
74.2 |
|
Net profit, bln rub |
? |
|
-104.4 |
-88.7 |
-28.2 |
10.1 |
40.0 |
|
33.4 |
|
|
OCF, bln rub |
? |
|
-162.6 |
-26.9 |
-6.69 |
-18.4 |
-25.3 |
|
-65.7 |
|
CAPEX, bln rub |
? |
|
20.9 |
15.5 |
10.8 |
12.9 |
2.25 |
|
9.76 |
|
FCF, bln rub |
? |
|
-183.5 |
-42.4 |
-17.5 |
-31.2 |
-27.6 |
|
-75.5 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
5.56 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
55.3% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
661.9 |
506.4 |
480.2 |
507.0 |
471.8 |
|
455.7 |
|
Cost of production, bln rub |
|
|
1.99 |
1.65 |
1.77 |
1.79 |
13.8 |
|
6.47 |
|
R&D, bln rub |
|
|
83.8 |
0.000 |
0.000 |
0.000 |
51.8 |
|
7.89 |
|
Interest expenses, bln rub |
|
|
0.845 |
7.63 |
11.0 |
11.2 |
10.8 |
|
12.1 |
|
|
Assets, bln rub |
|
|
1 149 |
1 113 |
1 113 |
1 155 |
1 262 |
|
1 201 |
|
Net Assets, bln rub |
? |
|
749.5 |
651.0 |
904.1 |
588.4 |
973.7 |
|
969.6 |
|
Debt, bln rub |
|
|
41.4 |
106.8 |
103.2 |
96.9 |
134.4 |
|
133.2 |
|
Cash, bln rub |
|
|
123.2 |
144.4 |
121.7 |
82.2 |
77.2 |
|
110.8 |
|
Net debt, bln rub |
|
|
-81.9 |
-37.6 |
-18.5 |
14.7 |
57.1 |
|
22.4 |
|
|
Ordinary share price, rub |
|
|
25.5 |
4.84 |
8.72 |
9.40 |
4.60 |
|
1.58 |
|
Number of ordinary shares, mln |
|
|
26.8 |
27.4 |
28.0 |
29.3 |
30.5 |
|
30.9 |
|
|
Market cap, bln rub |
|
|
683 |
132 |
244 |
276 |
140 |
|
49 |
|
EV, bln rub |
? |
|
601 |
95 |
226 |
290 |
197 |
|
71 |
|
Book value, bln rub |
|
|
748 |
651 |
880 |
588 |
951 |
|
970 |
|
|
EPS, rub |
? |
|
-3.90 |
-3.24 |
-1.01 |
0.34 |
1.31 |
|
1.08 |
|
FCF/share, rub |
|
|
-6.85 |
-1.55 |
-0.62 |
-1.06 |
-0.91 |
|
-2.44 |
|
BV/share, rub |
|
|
27.9 |
23.8 |
31.4 |
20.1 |
31.2 |
|
31.4 |
|
|
EBITDA margin, % |
? |
|
-19.5% |
-19.2% |
0.07% |
8.79% |
15.0% |
|
14.0% |
|
Net margin, % |
? |
|
-19.4% |
-21.9% |
-6.23% |
1.89% |
7.23% |
|
6.31% |
|
FCF yield, % |
? |
|
-26.9% |
-32.0% |
-7.15% |
-11.3% |
-19.7% |
|
-154.6% |
|
ROE, % |
? |
|
-13.9% |
-13.6% |
-3.12% |
1.71% |
4.11% |
|
3.44% |
|
ROA, % |
? |
|
-9.08% |
-7.97% |
-2.53% |
0.87% |
3.17% |
|
2.78% |
|
|
P/E |
? |
|
-6.54 |
-1.49 |
-8.66 |
27.4 |
3.50 |
|
1.46 |
|
P/FCF |
|
|
-3.72 |
-3.12 |
-14.0 |
-8.83 |
-5.08 |
|
-0.65 |
|
P/S |
? |
|
1.27 |
0.33 |
0.54 |
0.52 |
0.25 |
|
0.09 |
|
P/BV |
? |
|
0.91 |
0.20 |
0.28 |
0.47 |
0.15 |
|
0.05 |
|
EV/EBITDA |
? |
|
-5.71 |
-1.22 |
765.4 |
6.20 |
2.37 |
|
0.96 |
|
Debt/EBITDA |
|
|
0.78 |
0.48 |
-62.7 |
0.31 |
0.69 |
|
0.30 |
|
|
R&D/CAPEX, % |
|
|
401.8% |
0.00% |
0.00% |
0.00% |
2 304% |
|
80.8% |
|
|
CAPEX/Revenue, % |
|
|
3.88% |
3.83% |
2.38% |
2.41% |
0.41% |
|
1.85% |
|
| eHealth shareholders |
